ABEONA THERAPEUTICS INC. (ABEO) [Rocket]

Date Filed

Type

Description

10/10/2023

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans:

09/29/2023

Seshadri Vishwas (CEO) has filed a Form 4 on ABEONA THERAPEUTICS INC.

Txns:

Paid exercise price by delivering 13,290 shares @ $3.93, valued at $52.2k

09/29/2023

Vazzano Joseph Walter (CFO) has filed a Form 4 on ABEONA THERAPEUTICS INC.

Txns:

Paid exercise price by delivering 6,230 shares @ $3.93, valued at $24.5k

09/29/2023

O'Malley Brendan M. (SVP, General Counsel) has filed a Form 4 on ABEONA THERAPEUTICS INC.

Txns:

Paid exercise price by delivering 6,557 shares @ $3.93, valued at $25.8k

09/29/2023

Alvino Mark (Director) has filed a Form 4 on ABEONA THERAPEUTICS INC.

Txns:

Sold 6,316 shares @ $3.9145, valued at $24.7k

09/29/2023

Alland Leila (Director) has filed a Form 4 on ABEONA THERAPEUTICS INC.

Txns:

Sold 7,246 shares @ $3.9014, valued at $28.3k

09/29/2023

Form 4 - Statement of changes in beneficial ownership of securities:

08/08/2023

8-K

Quarterly results

Docs:

"Abeona Therapeutics Reports Second Quarter 2023 Financial Results"

08/08/2023

10-Q

Quarterly Report for the period ended June 30, 2023

07/25/2023

Form 4 - Statement of changes in beneficial ownership of securities:

07/10/2023

Form 3 - Initial statement of beneficial ownership of securities:

07/07/2023

8-K

Other Events, Financial Statements and Exhibits  Interactive Data

Docs:

"Abeona Therapeutics Announces Closing of $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules"

07/06/2023

SC 13G/A

ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 15.3% stake in Abeona Therapeutics Inc.

07/03/2023

8-K

Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data

Docs:

"PRE-FUNDED COMMON STOCK PURCHASE WARRANT Abeona Therapeutics Inc. Warrant Shares : ______________ Issue Date: July ___ , 2023 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT certifies that, for value received, [●] or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof until this Warrant is exercised in full but not thereafter, to subscribe for and purchase from Abeona Therapeutics Inc., a Delaware corporation , up to _____ shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitions . Capitalized terms used and not otherwise defined herein shall have the meani...",
"Tel: 212 728 8000 Fax: 212 728 8111",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of July 3, 2023, between Abeona Therapeutics Inc., a Delaware corporation , and the purchasers identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act of 1933, as amended and the rules and regulations of the Securities and Exchange Commission thereunder, the Company desires to issue and sell to the several Purchasers, and the several Purchasers desire to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration t...",
"Abeona Therapeutics Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules"

07/03/2023

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]:

06/16/2023

Alvino Mark (Director) has filed a Form 4 on ABEONA THERAPEUTICS INC.

Txns: